Replies to post #71 on Compugen Ltd (CGEN)

[mlkrborn]

Compugen Ltd. (CGEN, $5.61, +$1.53, +37.50%) unveiled a new drug target for multiple epithelial tumors, or carcinomas, which the drug-development company said could lead to improved cancer treatments.